{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:47Z","timestamp":1793157947549,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.amjcard.2025.12.018","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:36:56Z","timestamp":1767080216000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Artificial Intelligence as a Prognostic Tool in Cardiac Amyloidosis: A Review"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0332-7081","authenticated-orcid":false,"given":"Darren","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Capustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Lee","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Finkielstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2025.12.018_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1026440","article-title":"Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies","volume":"9","author":"Porcari","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2014","journal-title":"Heart Failure Reviews"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2023-178243","article-title":"Limited Utility of Mayo 2012 Cardiac Staging System for Risk Stratification of Patients with Advanced Cardiac AL Amyloidosis - Analysis of a Uniformly Treated Cohort of 1275 Patients","volume":"142","author":"Khwaja","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis","volume":"6","author":"Michieli","year":"2024","journal-title":"JACC CardioOncology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0006","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jacc.2023.12.036","article-title":"Stratifying Disease Progression in Patients With Cardiac ATTR Amyloidosis","volume":"83","author":"Ioannou","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0007","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/13506129.2016.1221815","article-title":"Identification of prognostic markers in transthyretin and AL cardiac amyloidosis*","volume":"23","author":"Damy","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102208","article-title":"Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality","volume":"4","author":"Terentes-Printzios","year":"2025","journal-title":"JACC Advances"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamacardio.2024.4578","article-title":"Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy","volume":"10","author":"Ioannou","year":"2024","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2024.04.011","article-title":"Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis","volume":"84","author":"Ioannou","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-44912-x","article-title":"Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure","volume":"9","author":"Tahir","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0012","doi-asserted-by":"crossref","unstructured":"Fumagalli C, Ioannou A, Cappelli F, Maurer MJ, Razvi Y, Porcari A, Zampieri M, Perfetto F, Rauf MU, Mart\u00ednez-Naharro A, Venneri L, Petrie A, Whelan C, Wechalekar A, Lachmann HJ, Hawkins PN, Olivotto I, Marfella R, Ungar A, Marchionni N, Gillmore JD, Torto AD. Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis. JACC CardioOncology 2025. Available at: https:\/\/doi.org\/10.1016\/j.jaccao.2025.01.018. Accessed July 2025","DOI":"10.1016\/j.jaccao.2025.01.018"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circulation Heart Failure"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101568","article-title":"Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era","volume":"4","author":"M\u00fcller","year":"2025","journal-title":"JACC Advances"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2020.03.007","article-title":"Utility of Biomarkers in Cardiac Amyloidosis","volume":"8","author":"Pregenzer-Wenzler","year":"2020","journal-title":"JACC Heart Failure"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0019","article-title":"Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis","author":"Amadio","year":"2024","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ehjdh\/ztae022","article-title":"The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"5","author":"Pereyra","year":"2024","journal-title":"European Heart Journal - Digital Health"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/S2589-7500(23)00265-0","article-title":"Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study","volume":"6","author":"Spielvogel","year":"2024","journal-title":"The Lancet Digital Health"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317741","article-title":"Automated extracellular volume fraction measurement for diagnosis and prognostication in patients with light-chain cardiac amyloidosis","volume":"20","author":"Hwang","year":"2025","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0032","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeaf248","article-title":"Predicting Prognosis of Light-Chain Cardiac Amyloidosis by Magnetic Resonance Imaging and Deep Learning","author":"Wang","year":"2025","journal-title":"European Heart Journal - Cardiovascular Imaging"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0033","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/RCT.0000000000001671","article-title":"Predictive Model Based on Texture Analysis of Noncontrast Cardiac Magnetic Resonance Images for the Prognostic Evaluation of Cardiac Amyloidosis","volume":"49","author":"She","year":"2024","journal-title":"Journal of Computer Assisted Tomography"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0035","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2021.09.858","article-title":"Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis","volume":"78","author":"Bonnefous","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.70073","article-title":"Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis","author":"Venneri","year":"2025","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0016","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.mayocp.2021.04.023","article-title":"Artificial Intelligence\u2013Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis","volume":"96","author":"Grogan","year":"2021","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0017","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/jcdd11040118","article-title":"How Artificial Intelligence Can Enhance the Diagnosis of Cardiac Amyloidosis: A Review of Recent Advances and Challenges","volume":"11","author":"Kamel","year":"2024","journal-title":"Journal of Cardiovascular Development and Disease"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036533","article-title":"Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review","volume":"14","author":"Grogan","year":"2025","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033251","article-title":"Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real-World Evaluation of Clinical Characteristics and Outcomes","volume":"14","author":"Masri","year":"2025","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0023","first-page":"51","article-title":"Prognostic Value of 99mtechnetium-PYP SPECT Visual Grade in Patients with Transthyretin Cardiac Amyloidosis on Stabilization Therapy","author":"Pabon","year":"2025","journal-title":"Journal of Nuclear Cardiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11604-021-01221-6","article-title":"Usefulness of quantitative 99mTc-pyrophosphate SPECT\/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis","volume":"40","author":"Ogasawara","year":"2022","journal-title":"Japanese Journal of Radiology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0026","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0027","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and Extracellular Volume in Transthyretin Amyloidosis","volume":"12","author":"Mart\u00ednez-Naharro","year":"2018","journal-title":"JACC Cardiovascular imaging"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0028","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12968-020-00690-4","article-title":"Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance","volume":"22","author":"Martini","year":"2020","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/biomedicines11010193","article-title":"Deep Learning to Classify AL versus ATTR Cardiac Amyloidosis MR Images","volume":"11","author":"Germain","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-025-04700-0","article-title":"Evaluation of machine learning methods for prediction of heart failure mortality and readmission: meta-analysis","volume":"25","author":"Hajishah","year":"2025","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0037","author":"Mo"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0038","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/jcm9051334","article-title":"Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept Study","volume":"9","author":"Agibetov","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0039","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ijerph18030908","article-title":"Real-World Data and Machine Learning to Predict Cardiac Amyloidosis","volume":"18","author":"Garc\u00eda-Garc\u00eda","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002310","article-title":"Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy","volume":"10","author":"Aurich","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0041","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11886-022-01649-w","article-title":"Artificial Intelligence to Improve Risk Prediction with Nuclear Cardiac Studies","volume":"24","author":"Ju\u00e1rez-Orozco","year":"2022","journal-title":"Current Cardiology Reports"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-025-01686-3","article-title":"Fostering trust and interpretability: integrating explainable AI (XAI) with machine learning for enhanced disease prediction and decision transparency","volume":"20","author":"Agrawal","year":"2025","journal-title":"Diagnostic Pathology"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0043","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12911-025-02944-6","article-title":"The role of explainable artificial intelligence in disease prediction: a systematic literature review and future research directions","volume":"25","author":"Alkhanbouli","year":"2025","journal-title":"BMC Medical Informatics and Decision Making"},{"issue":"1","key":"10.1016\/j.amjcard.2025.12.018_bib0044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12911-024-02653-6","article-title":"Trustworthy and ethical AI-enabled cardiovascular care: a rapid review","volume":"24","author":"Mooghali","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0045","first-page":"1","article-title":"Exploring the Factors Influencing AI Integration in Clinical Diagnostic Decision-Making","volume":"3","author":"Saadati","year":"2025","journal-title":"Health Nexus"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0046","article-title":"Artificial Intelligence in Cardiac Amyloidosis: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Across Imaging and Non-Imaging Modalities","author":"Kumbalath","year":"2025","journal-title":"medRxiv (Cold Spring Harbor Laboratory)"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0047","doi-asserted-by":"crossref","DOI":"10.1186\/s44247-025-00187-z","article-title":"From diagnosis to management: unveiling the challenges of artificial intelligence solutions in cardiovascular healthcare","volume":"3","author":"Idakwo","year":"2025","journal-title":"BMC Digital Health"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0048","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.30574\/wjarr.2024.23.3.2907","article-title":"Ethical and clinical implications of AI integration in cardiovascular healthcare","volume":"23","author":"Ahmad","year":"2024","journal-title":"World Journal of Advanced Research and Reviews"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000278","article-title":"Bias in artificial intelligence algorithms and recommendations for mitigation","volume":"2","author":"Nazer","year":"2023","journal-title":"PLOS Digital Health"},{"key":"10.1016\/j.amjcard.2025.12.018_bib0050","article-title":"Uncovering the Challenges From Algorithmic Bias Affecting the Marginalized Patient Groups in Healthcare","author":"Bhatia","year":"2024","journal-title":"SSRN Electronic Journal"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492500757X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492500757X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:40:15Z","timestamp":1787863215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291492500757X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S000291492500757X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.12.018","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence as a Prognostic Tool in Cardiac Amyloidosis: A Review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}